What's happened
The U.S. Supreme Court is considering whether EPA's approval of Roundup without a cancer warning should dismiss state court claims. The case involves Bayer, which faces lawsuits linking glyphosate to cancer, amid conflicting scientific opinions and political interventions from the Trump and Biden administrations. The decision could impact regulatory and legal standards.
What's behind the headline?
The Supreme Court's upcoming decision will significantly influence the legal landscape for glyphosate. The case hinges on whether federal approval by the EPA precludes state court claims, a question that pits regulatory authority against state-level litigation. The Trump administration's support for Bayer, reversing the Biden administration's stance, underscores political influence in environmental regulation. The conflicting scientific evidence—some studies linking glyphosate to cancer versus EPA's safety assessments—reflects broader debates over scientific integrity and corporate influence. This ruling will likely set a precedent for how federal and state laws interact in environmental health cases, impacting future litigation and regulatory policies. The case also highlights the ongoing tension between public health concerns and agricultural interests, with potential consequences for farmers, consumers, and environmental advocates.
What the papers say
The New York Times reports that Bayer's CEO, Bill Anderson, claims the court's decision is 'good news for U.S. farmers,' emphasizing regulatory clarity. The Independent notes the Supreme Court will decide if EPA's approval should block state claims, with the Trump administration supporting Bayer's immunity, reversing the Biden administration's position. AP News highlights the scientific controversy, with some studies linking glyphosate to cancer, though the EPA maintains it is unlikely to be carcinogenic when used properly. These contrasting perspectives reveal the complex interplay of science, politics, and law in this high-stakes case, illustrating how regulatory decisions can be influenced by political shifts and corporate interests.
How we got here
Roundup, developed by Monsanto in the 1970s and now owned by Bayer, has faced decades of controversy over its safety. While the EPA considers it safe when used as directed, some studies suggest a link to cancer. The legal battles intensified after a scientific journal retracted a review supporting glyphosate's safety, citing potential bias from Monsanto scientists. The case now before the Supreme Court questions whether federal approval should shield Bayer from state-level lawsuits, amid ongoing regulatory reviews due by October 2026.
Go deeper
More on these topics
-
Bayer AG is a German multinational pharmaceutical and life sciences company and one of the largest pharmaceutical companies in the world.
-
The Supreme Court of the United States is the highest court in the federal judiciary of the United States of America. It has ultimate appellate jurisdiction over all federal and state court cases that involve a point of federal law, and original jurisdict
-
Glyphosate is a broad-spectrum systemic herbicide and crop desiccant. It is an organophosphorus compound, specifically a phosphonate, which acts by inhibiting the plant enzyme 5-enolpyruvylshikimate-3-phosphate synthase.